Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 4(19), p. 213-219.e4, 2019
DOI: 10.1016/j.clml.2018.12.012
Links
Tools
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial
Journal article published in 2019 by
Guillermo Garcia-Manero,
Antonio Almeida 
,
Pierre Fenaux,
Norbert Gattermann,
Aristoteles Giagounidis,
Stuart L. Goldberg,
Keiya Ozawa,
Jerry Weaver,
Valeria Santini
,
Pierre Fenaux,
Norbert Gattermann,
Aristoteles Giagounidis,
Stuart L. Goldberg,
Keiya Ozawa,
Jerry Weaver,
Valeria Santini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 